Dr. Kitko is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2220 Pierce Ave
Nashville, TN 37232- Is this information wrong?
Education & Training
- University of Michigan Health SystemFellowship, Pediatric Hematology/Oncology, 2003 - 2006
- Duke University HospitalChief Residency, Pediatrics, 2002 - 2003
- Duke University HospitalResidency, Pediatrics, 1999 - 2002
- Ohio State University College of MedicineClass of 1999
- Denison UniversityB.S., Summa Cum Laude, 1991 - 1995
Certifications & Licensure
- AL State Medical License 2017 - 2024
- TN State Medical License 2015 - 2024
- MI State Medical License 2003 - 2016
- NC State Medical License 1999 - 2004
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Fludarabine-based Conditioning for Severe Aplastic Anemia (BMT CTN 0301) Start of enrollment: 2006 Jan 01
- Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801) Start of enrollment: 2010 Apr 01
- Predictive Biomarkers For Pediatric Chronic Graft-Versus-Host Disease Start of enrollment: 2013 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsSeverity of Chronic Graft-versus-Host Disease and Late Effects Following Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancy.Catherine J Lee, Tao Wang, Karen Chen, Mukta Arora, Ruta Brazauskas, Stephen R Spellman, Carrie Kitko, Margaret L MacMillan, Joseph A Pidala, Sherif M Badawy, Neel Bha...> ;Transplantation and Cellular Therapy. 2024 Jan 1
- 1 citationsUnderstanding and treatment of cutaneous graft-versus-host-disease.Junshik Hong, Johnathan Fraebel, Yenny Yang, Eric Tkacyk, Carrie Kitko, Tae Kon Kim> ;Bone Marrow Transplantation. 2023 Dec 1
- 1 citationsPilot Study of Donor-Engrafted Clonal Hematopoiesis Evolution and Clinical Outcomes in Allogeneic Hematopoietic Cell Transplantation Recipients Using a National Registry.Nancy Gillis, Eric Padron, Tao Wang, Karen Chen, Jakob D DeVos, Stephen R Spellman, Stephanie J Lee, Carrie L Kitko, Margaret L MacMillan, Jeffrey West, Yi-Han Tang, M...> ;Transplantation and Cellular Therapy. 2023 Oct 1
- Join now to see all
Journal Articles
- TNF-inhibition with etanercept for graft versus host disease prevention in high risk HCT: Lower TNFR1 levels correlate with better outcomeChoi SW, Stiff P, Cooke K, Ferrara JLM, Braun T, Kitko C, Reddy P, Yanik G, Mineishi S, Paczesny S, Hanauer D, Pawarode A, Peres E, Rodriguez T, Smith S, Levine JE, Biol Blood Marrow Transplant, 1/1/2012
- Impact of immune modulation with in vivo T-cell depletion and myleoablative total body irradiation conditioning on outcome after unrelated donor transplantation for ch...Veys P, Wynn RF, Ahn KW, Samarasinghe S, He W, Bonney D, Craddock J, Cornish J, Davies SM, Dvorak CC, Duerst RE, Gross TG, Kapoor N, Kitko C, Krance RA, Leung W, Lewis..., Blood, 1/1/2012
- Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignanciesMagenau J, Tobai H, Pawarode A, Braun T, Peres E, Reddy P, Kitko C, Choi S, Yanik G, Frame D, Harris A, Erba H, Kujawski L, Elenitoba-Johnson K, Sanks J, Jones D, Pacz..., Blood, 1/1/2011
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- The MAGIC Algorithm Probability (MAP): A Novel Laboratory Biomarker for the Response to Treatment of Acute Graft-Versus-Host DiseaseCarrie Kitko, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Next Generation Sequence Minimal Residual Disease (NGS-MRD) Predicts Outstanding Event Free Survival (EFS) Regardless of Hematopoietic Cell Transplantation (HCT) Prepa...Carrie Kitko, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- National Institutes of Health (NIH) consensus criteria describe the clinical features of chronic graft-versus-host disease (cGVHD) in children and improve and accuracy...Cuvelier G, Nemecek E, Boyer M, Wahlstrom J, Kitko C, Jacobsohn D, Coulter D, Chewning A, McDonald S, Lewis V, Schechter T, Morris J, Halevy A, Schultz K, American Society of Blood and Marrow Transplant Meeting, Honolulu, HI, 1/1/2016
- Join now to see all
Lectures
- Efficacy of Methoxsalen Sterile Solution in Conjunction with the Therakos¬ Cellex¬ Photopheresis System in Pediatric Patients with Steroid-Refractory Acute GvHD: Inter...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Highlights from ASH 2014: Pediatric Hematology/OncologyDearborn, MI - 1/1/2015
- Chronic GVHD Biomarker Discovery: A Pathway to Better Treatments1/1/2014
- Join now to see all
Press Mentions
- High-Dose Flu Vaccine Beneficial for Pediatric Stem Cell Transplant PatientsMarch 2nd, 2023
- Syndax Pharmaceuticals and Incyte Announce Axatilimab Phase 1/2 Data in Patients with Chronic Graft-Versus-Host Disease Published in the Journal of Clinical OncologyDecember 5th, 2022
- New Cutting-Edge Treatment for Type of Pediatric Leukemia Offered at Monroe Carell Jr. Children’s Hospital at VanderbiltSeptember 18th, 2017
- Join now to see all
Committees
- Committee member, ASH Communications Committee
Professional Memberships
- American Society for Blood and Marrow TransplantationMember
Hospital Affiliations
- Monroe Carell Jr. Childrens HospitalNashville, Tennessee
- Vanderbilt University Medical CenterNashville, Tennessee
External Links
- Vanderbilt Pediatric Stem Cell Transplanthttp://www.childrenshospital.vanderbilt.org/services.php?mid=1248
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: